Validation and Standardisation of a Pool of Simplified Evaluation Aimed to the Diagnoses of Aphasic Disorders and Adapted to the Patients Suffering an Acute Phase of Stroke

• Conditions: Stroke
• Interventions: Other: BESTA scale

• Registration Number: NCT02548481
• Lead Sponsor: University Hospital, Limoges

Brief Summary

Every year in France, from 100 000 to 145 000 people are affected by a stroke. 75% patients survived with aftereffects, in particular aphasic disorders.

A sketch of a new tool called BESTA aiming to a rapid handover to the acute phase post stroke had been worked out. After a meeting, 13 multidisciplinary experts have discussed, adjusted and a new complete tool (BESTA) had been created in order to evaluate the different states of aphasia.

The goal of this study is the validation and the standardization of this new BESTA tool.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2015-09-09
• Study First Submitted QC: 2015-09-10
• Study First Posted: 2015-09-14
• Study Start: 2015-11
• Status Verified: 2020-03
• Last Update Submitted: 2020-05-29
• Last Update Posted: 2020-06-01
• Primary Completion: 2020-12
• Study Completion: 2021-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 395

Inclusion Criteria

Patients with stroke:

• Every patient over 18,
• admitted among neuro-vascular unit,
• native french speaker,
• the level of vigilance is satisfactory in order to allow a speech therapy test.

Healthy Volunteers:

• Every volunteers over 18,
• without any medical history of a stroke or any speech disorders,
• native french speaker.

Exclusion Criteria

Patients with stroke and Healthy Volunteers :

• dementia disease
• psychiatric condition
• non-equipped deafness
• pregnant woman
• patient with medical histories of stroke

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
BESTA scale	BESTA scale	BESTA scale is administered at T0, T1 (3 months) and T2 (1 year)

Primary Outcome Measures

Name	Time	Method
validity of concomitant criterion at T0 versus LAST	1 day	T0: the gold standard was determined by the expert group is the LAST screening tool.; The tool to be evaluated is the BESTA at T0. However, as written expression is not evaluated in the LAST, only the dimensions and Oral Expression Listening Comprehension of BESTA may actually be faced with LAST scale.

Trial Locations

Locations (1)

Limoges Hospital; 🇫🇷 Limoges, France